New research finds that people with schizophrenia have a genetic propensity to smoking and a reduced genetic risk of obesity.
Novo Nordisk’s US semaglutide manufacturing site under the spotlight again as 2022 monitoring issue surfaces
Novo Nordisk’s US facility has had at least four quality control issues related to microbes in the past two years. Its Clayton, NC site manufactures